| 000 | 01799 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515222135.0 | ||
| 264 | 0 | _c20100706 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2010.82 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoreau, P | |
| 245 | 0 | 0 |
_aStem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 2010 |
||
| 300 |
_a1233-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aBoronic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
| 650 | 0 | 4 | _aHematopoietic Stem Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukapheresis _xmethods |
| 650 | 0 | 4 |
_aMultiple Myeloma _xtherapy |
| 650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aHulin, C | |
| 700 | 1 | _aMarit, G | |
| 700 | 1 | _aCaillot, D | |
| 700 | 1 | _aFacon, T | |
| 700 | 1 | _aLenain, P | |
| 700 | 1 | _aBerthou, C | |
| 700 | 1 | _aPégourié, B | |
| 700 | 1 | _aStoppa, A M | |
| 700 | 1 | _aCasassus, P | |
| 700 | 1 | _aMichallet, M | |
| 700 | 1 | _aBenboubker, L | |
| 700 | 1 | _aMaisonneuve, H | |
| 700 | 1 | _aDoyen, C | |
| 700 | 1 | _aLeyvraz, S | |
| 700 | 1 | _aMathiot, C | |
| 700 | 1 | _aAvet-Loiseau, H | |
| 700 | 1 | _aAttal, M | |
| 700 | 1 | _aHarousseau, J L | |
| 773 | 0 |
_tLeukemia _gvol. 24 _gno. 6 _gp. 1233-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2010.82 _zAvailable from publisher's website |
| 999 |
_c19784913 _d19784913 |
||